InMed Pharmaceuticals (INM) Short-term Investments (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Short-term Investments of $41625.0 for Q1 2026, up 2.57% year-over-year from $40582.0 in Q1 2025, and down 2.46% quarter-over-quarter from $42675.0 in Q4 2025.
InMed Pharmaceuticals (INM) Short-term Investments (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Short-term Investments history runs 7 years deep, the most recent figure standing at $41625.0 for Q1 2026.
- In Q1 2026, Short-term Investments rose 2.57% year-over-year to $41625.0; the TTM figure through Mar 2026 stood at $41625.0 (up 2.57% YoY), while the FY2025 annual figure was $43384.0, up 0.74% from the prior year.
- Short-term Investments for Q1 2026 stood at $41625.0, down from $42675.0 in the prior quarter.
- The five-year high for Short-term Investments was $46098.0 in Q1 2022, with the low at $40582.0 in Q1 2025.
- The 5-year median for Short-term Investments is $43055.0 (2023), against an average of $43072.1.
- The sharpest annual moves came in 2024 and 2025: Short-term Investments declined 8.27% in 2024, then gained 4.63% in 2025.
- InMed Pharmaceuticals' Short-term Investments stood at $43053.0 in 2022, then climbed by 3.27% to $44462.0 in 2023, then slipped by 8.27% to $40787.0 in 2024, then advanced by 4.63% to $42675.0 in 2025, then declined by 2.46% to $41625.0 in 2026.
- Business Quant data shows INM's Short-term Investments at $41625.0 in Q1 2026, $42675.0 in Q4 2025, and $42859.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | InMed Pharmaceuticals | 6.38 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,625.00 |
| Dec 31, 2025 | 42,675.00 |
| Sep 30, 2025 | 42,859.00 |
| Jun 30, 2025 | 43,384.00 |
| Mar 31, 2025 | 40,582.00 |
| Dec 31, 2024 | 40,787.00 |
| Sep 30, 2024 | 43,203.00 |
| Jun 30, 2024 | 43,064.00 |
| Mar 31, 2024 | 43,085.00 |
| Dec 31, 2023 | 44,462.00 |
| Sep 30, 2023 | 42,942.00 |
| Jun 30, 2023 | 44,422.00 |
| Mar 31, 2023 | 43,055.00 |
| Dec 31, 2022 | 43,053.00 |
| Sep 30, 2022 | 42,125.00 |
| Jun 30, 2022 | 44,804.00 |
| Mar 31, 2022 | 46,098.00 |
| Dec 31, 2021 | 45,424.00 |
| Sep 30, 2021 | 45,132.00 |
| Jun 30, 2021 | 46,391.00 |